Dendritic cells and the shadow line between autoimmunity and disease
Open Access
- 7 January 2005
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (1) , 11-15
- https://doi.org/10.1002/art.20758
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expressionArthritis & Rheumatism, 2005
- Requirement of dying cells and environmental adjuvants for the induction of autoimmunityArthritis & Rheumatism, 2004
- Interferon‐α: A new target for therapy in systemic lupus erythematosus?Arthritis & Rheumatism, 2003
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003
- Successful treatment of collagen‐induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activityArthritis & Rheumatism, 2003
- High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritisArthritis & Rheumatism, 2003
- Disposal of dying cells: A balancing act between infection and autoimmunityArthritis & Rheumatism, 2003
- Opsonization of Apoptotic Cells by Autologous iC3b Facilitates Clearance by Immature Dendritic Cells, Down-regulates DR and CD86, and Up-regulates CC Chemokine Receptor 7The Journal of Experimental Medicine, 2002
- Adjuvants of ImmunityThe Journal of Experimental Medicine, 2002
- Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.Journal of Clinical Investigation, 1995